
Angelica C. Marrero, MD
Physician, longevity and cardiometabolic healthLicense verified
Angelica C. Marrero, MD, is a U.S.-licensed physician focused on longevity and cardiometabolic health. She reviews the evidence behind popular health treatments, including GLP-1 medications. She reviews content on glp1.health for medical accuracy only and does not rank, endorse or recommend any provider. Disclosure: Dr. Marrero is a co-founder of a telemedicine practice that prescribes GLP-1 medications.
Reviews for medical accuracy only. Doesn't rank, endorse or recommend providers. How medical review works
Credentials
| Medical license | Puerto Rico Doctor of Medicine license 25228. Active since August 13, 2026, expires August 27, 2028. Board actions: none on file. Verify on DocInfo (Federation of State Medical Boards)Checked on DocInfo (Federation of State Medical Boards) on November 2, 2026. |
|---|---|
| NPI | 1003549015. Look it up in the NPPES registry |
| Education | MD, University of Medicine and Health Sciences, St. Kitts |
| Areas of focus | GLP-1 medications, Cardiometabolic health, Longevity medicine, Dermatology |
Experience
- Co-founder, NuVi Clinic, a telemedicine practice that prescribes GLP-1 medications
Selected publications
- The face of emotion: Botulinum toxin, emotional anatomy, and mood modulation. Journal of Cosmetic Dermatology, 2025.
- Amivantamab, the first epidermal growth factor receptor and mesenchymal–epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia. JAAD Case Reports, 2024.
- Acrodermatitis dysmetabolica with concomitant acquired acrodermatitis enteropathica in a patient with maple syrup urine disease. JAAD Case Reports, 2024.
What Dr. Marrero reviews
- Dr. Marrero checks what a page says about medicines, side effects, safety and regulation, for medical accuracy only.
- Reviewers don’t rank, endorse or recommend providers, and they don’t set headings, scores, prices or rankings.
- The credit covers only the version the reviewer approved in writing. Any later change to the page’s text removes it until the reviewer approves the new version.
- Reviewers are paid per review, never per provider, sign-up or click.
Pages reviewed by Dr. Marrero
| Collective Review: Is It Legit? We Checked Its Price, Membership and FDA Record | Reviewed Nov 2, 2026 |
| Compounded Semaglutide: Does It Work, Is It Safe, and Is It Still Legal? | Reviewed Nov 2, 2026 |
| Compounded Tirzepatide: Is It Safe, Is It Legal, and What Changed? | Reviewed Nov 2, 2026 |
| Lttl Review: Is It Legit? We Checked Its Prices, Pharmacies and FDA Record | Reviewed Nov 2, 2026 |
| Semaglutide & tirzepatide dose converter: mg ↔ units | Reviewed Nov 2, 2026 |
| Semaglutide Units to mg: How Many mg Is 20, 40 or 50 Units of Semaglutide? | Reviewed Nov 2, 2026 |
Elsewhere
Profile last updated November 2, 2026.